SCHEMBL25693456

SCHEMBL25693456

CC1OC(C)(C(=O)O)C(O)C(O)C1O

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IDUA P35475 1/20 0.37
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18819594 0.94 IDUA (0.34) IDUAMAPK1
SCHEMBL13134061 0.81 IDUA (0.38) IDUAMAPK1
SCHEMBL13134062 0.81 IDUA (0.38) IDUAMAPK1
SCHEMBL17256226 0.81 IDUA (0.38) IDUAMAPK1
SCHEMBL9385852 0.77 IDUA (0.38) IDUA
SCHEMBL23358401 0.75 PYGB (0.44) —
SCHEMBL25696296 0.75 IDUA (0.34) IDUA
SCHEMBL21386691 0.75 IDUA (0.34) IDUA
SCHEMBL18820165 0.75 PYGB (0.44) —
SCHEMBL12764243 0.72 PYGB (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122494-A1 COMPOSITIONS AND METHODS OF USE TO TREAT 12-LIPOXYGENASE (12-LOX) MEDIATED DISEASES VERALOX THERAPEUTICS (US) 2023-06-29 — — WO disclosed
Send feedback